reports
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies ...
IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024 WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures. “Being recognized by Fortune as o...
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results...
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports GAAP diluted EPS of $0.40 and Non-GAAP diluted EPS of $0.43 for the third quarter of 2024.Raising year end guidance on GAAP diluted earnings per share to $1.49 to $1.52 from $1.37 to $1.47, and Non-GAAP diluted earnings per share to $1.64 to $1.67 from $1.52 to $1.62. Declares a regular quarterly cash...
Altair Announces Third Quarter 2024 Financial Results
Altair Announces Third Quarter 2024 Financial Results TROY, Mich., Oct. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), today released its financial results for the third quarter and nine months ended September 30, 2024. Immediately prior to the dissemination of this press release, Altair issued a press release announcing that it has entered into a merger agreement with a subsidiary of Siemens pursuant to which Altair will be acquired and stockholders of Altair will receive cash merger consideration as more fully described in that press release. Third Quarter 2024 Financial Re...
Altair Signs Definitive Agreement with Siemens to be Acquired for $10....
Altair Signs Definitive Agreement with Siemens to be Acquired for $10.6 Billion Altair Stockholders to Receive $113 Per Share in Cash TROY, Mich., Oct. 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, today announced that it has entered into a definitive agreement to be acquired by Siemens, a leading technology company focused on industry, infrastructure, mobility, and healthcare. Altair stockholders will receive $113.00 per share in cash, representing an equity value of approximately $10.6 billion. The $113.00 per share cash consideration re...
Altair Engineering Inc: 1 director
A director at Altair Engineering Inc sold 13,000 shares at 102.592USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Altair Announces Date of Third Quarter 2024 Financial Results Conferen...
Altair Announces Date of Third Quarter 2024 Financial Results Conference Call TROY, Mich., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, will release its financial results for the third quarter ended September 30, 2024 after the market close on Wednesday, October 30, 2024. On that day, management will hold a conference call and webcast at 5 p.m. ET to review and discuss the Company’s third quarter 2024 results and fourth quarter and full year 2024 outlook. A recorded version of this webcast will be available after the call and accessible...
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare ...
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference WINTER SPRINGS, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that it will participate in the 3rd Annual ROTH Healthcare Opportunities Conference. Iradimed’s CFO, Jack Glenn, will host one-on-one meetings with investors at the 3rd Annual ROTH Healthcare Opportunities Conference at the Metropolitan Club in New York on October 9, 2024. About I...
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas ...
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference WINTER SPRINGS, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today that the Company will be participating in the Lake Street 8th Annual Best Ideas Growth "Big 8" Conference. Iradimed management will host one-on-one meetings between company management and investors at the Lake Street 8th Annual Best Ideas Growth "Big 8" Conference at the ...
Altair Responds to Matrix Capital Management Statement on Altair Holdi...
Altair Responds to Matrix Capital Management Statement on Altair Holdings TROY, Mich., Aug. 20, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, today responded to a . “In response to today’s announcement from Matrix Capital Management, we appreciate its strong support over the years and its decision to maintain its full position in Altair, recognizing our long-term strategic value,” said James R. Scapa, founder, chairman, and chief executive officer, Altair. About Altair Altair is a global leader in computational intelligence that provides softw...
Altair Announces Second Quarter 2024 Financial Results
Altair Announces Second Quarter 2024 Financial Results Altair Exceeds Revenue Expectations for the Second Quarter TROY, Mich., Aug. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, today released its financial results for the second quarter and six months ended June 30, 2024. “Altair maintained its strong trajectory during the second quarter, with software revenue and total revenue above the high end of guidance,” said James R. Scapa, founder, chairman, and chief executive officer, Altair. “Our Q2 results underscore the robustness of our soft...
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Result...
IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $17.9 million for the second quarter of 2024, an increase of 11.2 percent over the comparable period 2023.Reports GAAP diluted EPS of $0.38 and non-GAAP diluted EPS of $0.42 for the second quarter of 2024.Reports second quarter of 2024 operating income of $5.6 million, an increase of 13.4 percent compared to the comparable period of 2023. Declares a regular quarterly cash dividend of $0.15 per common share for the thi...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Con...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, August 1, 2024. Iradimed management will host a conference call the same day beginning at 12:00 p.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a d...
Altair Announces Date of Second Quarter 2024 Financial Results Confere...
Altair Announces Date of Second Quarter 2024 Financial Results Conference Call TROY, Mich., July 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, will release its financial results for the second quarter ended June 30, 2024, after the market close on Thursday, August 1, 2024. On that day, management will hold a conference call and webcast at 5 p.m. ET to review and discuss the Company’s second quarter 2024 results and third quarter and full year 2024 outlook. A recorded version of this webcast will be available after the call and accessible at ....
Altair Signs Agreement to Acquire Metrics Design Automation Inc. Expan...
Altair Signs Agreement to Acquire Metrics Design Automation Inc. Expands Footprint in EDA Industry Flagship product, DSim, is the first-of-its-kind EDA simulation as a service solution TROY, Mich., July 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, announced it has entered into a definitive agreement to acquire all of the outstanding capital stock of Metrics Design Automation Inc. (Metrics), a Canadian company with a game changing simulation as a service (SaaS) business model for semiconductor electronic functional simulation and design ver...
Altair Added to S&P MidCap 400
Altair Added to S&P MidCap 400 TROY, Mich., June 20, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, was added to the S&P MidCap 400 by S&P Dow Jones Indices effective prior to the open of trading on Monday, June 24. “Being added to the S&P 400 represents a significant milestone in Altair's journey as a public company,” said James R. Scapa, founder and chief executive officer, Altair. “It is a testament to our strong and steady growth and our demonstrated leadership in simulation and design, data analytics and AI, and high-performance computing.” ...
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market Trading to commence effective on the market open June 14, 2024 WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Global Market, effective June 14, 2024, and will continue under the ticker symbol “IRMD.” Stockholders are not required to take any action due to the uplisting. Roger Susi, Preside...
Advanced Drainage Systems Inc: 3 directors
Three Directors at Advanced Drainage Systems Inc sold after exercising options/sold 87,007 shares at between 170.685USD and 173.107USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary...
Altair to Present at Upcoming Investor Conferences
Altair to Present at Upcoming Investor Conferences TROY, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, today announced that Matt Brown, chief financial officer, will present in a fireside chat at each of the following investor conferences: Event:William Blair Growth Stock ConferenceWhen:Wednesday, June 5, 2024Location:Chicago, ILTime:12:40 p.m. CT (1:40 p.m. ET) Event:Baird Global Consumer, Technology & Services ConferenceWhen:Thursday, June 6, 2024Location:New York, NYTime:11:25 a.m. ET Event:NASDAQ London Investor Conference in...
Altair Announces First Quarter 2024 Financial Results
Altair Announces First Quarter 2024 Financial Results Altair Achieves Record Software Revenue and Total Revenue for the First Quarter TROY, Mich., May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALTR), a global leader in computational intelligence, today released its financial results for the first quarter ended March 31, 2024. “Altair continued its positive momentum into the start of 2024, with record-high quarterly software revenue and total revenue,” said James R. Scapa, founder, chairman, and chief executive officer, Altair. “The first quarter exceeded our expectations and demonstrates ...
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results...
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023.Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024. WINTER SPRINGS, Fla., May ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.